-
IntroducedMar 06, 2023
-
Passed House
-
Passed Senate
-
Signed into Law
Prescription Drugs; Requires drug manufacturers to notify DBPR of reportable drug price increases; prohibits manufacturers from claiming public records exemption for trade secrets for information provided in forms or reports; requires DFS to designate employee as primary contact on issues relating to PBMs; provides penalty for persons who do not hold certificate of authority to act as administrator; requires PBMs to identify ownership affiliations to office; provides requirements for contracts between PBM & participating pharmacy; provides for biennial examinations of PBMs. APPROPRIATION: $1,127,525
Last Action See all actions
House • May 01, 2023: Laid on Table; companion bill(s) passed, see CS/CS/SB 1550 (Ch. 2023-29), CS/SB 1552 (Ch. 2023-30)
Latest Bill Text See all bill texts
Summary/Bill Text
Comments on HB 1509
Tweets
Whip Lists
Sponsors
- Health & Human Services Committeeprimary
- Appropriations Committeeprimary
- Healthcare Regulation Subcommitteeprimary
- Chaneyprimary
- Abbottcosponsor
- Amestycosponsor
- Andersoncosponsor
- Bakercosponsor
- Banksoncosponsor
- Barnabycosponsor
- Bartlemancosponsor
- Bellcosponsor
- Carusocosponsor
- Crosscosponsor
- Gonzalez Pittmancosponsor
- Gossett-Seidmancosponsor
- Gottliebcosponsor
- Jacquescosponsor
- Killebrewcosponsor
- Leekcosponsor
- Lopez, V.cosponsor
- Massullocosponsor
- Melocosponsor
- Salzmancosponsor
- Steelecosponsor
- Tuckcosponsor
- Waldroncosponsor
- Woodsoncosponsor
Votes
Actions
- May 01, 2023 | House
- Laid on Table; companion bill(s) passed, see CS/CS/SB 1550 (Ch. 2023-29), CS/SB 1552 (Ch. 2023-30)
- Apr 25, 2023 | House
- Laid on Table under Rule 7.18(a)
- CS Filed
- Bill referred to House Calendar
- 1st Reading (Committee Substitute 3)
- Added to Second Reading Calendar
- Apr 24, 2023 | House
- Favorable with CS by Health & Human Services Committee
- 1st Reading (Committee Substitute 2)
- Reported out of Health & Human Services Committee
- Apr 23, 2023 | House
- Added to Health & Human Services Committee agenda
- Apr 22, 2023 | House
- Referred to Health & Human Services Committee
- Now in Health & Human Services Committee
- Apr 21, 2023 | House
- Favorable with CS by Appropriations Committee
- Reported out of Appropriations Committee
- Laid on Table under Rule 7.18(a)
- CS Filed
- Apr 20, 2023 | House
- Added to Appropriations Committee agenda
- Apr 04, 2023 | House
- Referred to Appropriations Committee
- Referred to Health & Human Services Committee
- Now in Appropriations Committee
- Apr 03, 2023 | House
- Reported out of Healthcare Regulation Subcommittee
- Laid on Table under Rule 7.18(a)
- CS Filed
- 1st Reading (Committee Substitute 1)
- Mar 28, 2023 | House
- Favorable with CS by Healthcare Regulation Subcommittee
- Mar 24, 2023 | House
- Added to Healthcare Regulation Subcommittee agenda
- Mar 09, 2023 | House
- Referred to Healthcare Regulation Subcommittee
- Referred to Appropriations Committee
- Referred to Health & Human Services Committee
- Now in Healthcare Regulation Subcommittee
- Mar 07, 2023 | House
- 1st Reading (Original Filed Version)
- Mar 06, 2023 | House
- Filed
Bill Texts
- H 1509 FiledPDF
- H 1509 c1PDF
- H 1509 c2PDF
- H 1509 c3PDF
- Committee Strike All Amendment 430279 (Withdrawn Prior to Consideration 3/27/2023) -- ChaneyPDF
- Committee Strike All Amendment 622887 (Adopted without Objection 3/28/2023) -- ChaneyPDF
- Committee Strike All Amendment 469723 (Adopted without Objection 4/21/2023) -- ChaneyPDF
- Committee Amendment to Amendment 337637 (Adopted without Objection 4/21/2023) -- ChaneyPDF
- Committee Amendment 686695 (Adopted without Objection 4/24/2023) -- ChaneyPDF